Skip to main content
logo
Nuo Therapeutics, Inc. (AURX)
OTCMKTS · Delayed Price · Currency is USD
1.270
-0.030 (-2.31%)
Oct 19, 2026, 1:05 PM EST

Nuo Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
5.23.311.370.610.11-
Revenue Growth
166.61%142.72%124.34%442.12%--
Gross Profit
3.332.221.060.480.09-
Operating Income
-1.73-2.52-2.46-3.17-3.32-0.09
Net Income
-2.01-2.51-2.32-3.17-3.17-0.89
Earnings Per Share
-0.04-0.05-0.05-0.08-0.08-0.03
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.450.550.280.932.051.41
Total Debt
1.810.60.160.260.34-
Net Cash (Debt)
-1.36-0.050.120.671.721.41
Net Cash Growth
---82.25%-60.78%21.32%776.26%
Net Cash Per Share
-0.03-0.000.000.020.040.05

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-2.15-0.86-2.23-3.17-3.71-0.12
Capital Expenditures
-0.3-0.27-0.15-0.01-0.06-
Free Cash Flow
-2.45-1.14-2.39-3.18-3.77-0.12
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
64.11%66.94%77.82%79.28%82.88%-
Operating Margin
-33.32%-75.95%-180.04%-520.65%-2958.21%-
Pretax Margin
-38.70%-75.82%-170.21%-521.17%-2825.60%-
Profit Margin
-38.70%-75.82%-170.21%-521.17%-2825.60%-
FCF Margin
-47.06%-34.40%-174.82%-521.76%-3355.12%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
12.1128.6448.0139.99558.56-